Departmental Papers (BE)

Document Type

Journal Article

Date of this Version



The artificial heart, after decades of development, remains a long way off as a practical remedy for people with failing hearts. But a related technology, the left ventricular assist device (LVAD), has passed major milestones in its development and is poised for widespread use. This technology, which is an offshoot of the artificial heart program, may well have greater impact on society than the artificial heart. It is time to consider its probable costs to society. A heart transplant is the present treatment of choice for end-stage heart failure (ESHF).


Copyright 2004 IEEE. Reprinted from IEEE Technology and Society Magazine, Volume 23, Issue 2, Summer 2004, pages 23-27.

This material is posted here with permission of the IEEE. Such permission of the IEEE does not in any way imply IEEE endorsement of any of the University of Pennsylvania's products or services. Internal or personal use of this material is permitted. However, permission to reprint/republish this material for advertising or promotional purposes or for creating new collective works for resale or redistribution must be obtained from the IEEE by writing to By choosing to view this document, you agree to all provisions of the copyright laws protecting it.



Date Posted: 22 November 2005

This document has been peer reviewed.